These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35611229)

  • 61. Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2018 Aug; 43(4):500-506. PubMed ID: 29722046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia.
    Breaux S; Desrosiers FAD; Neira M; Sinha S; Nislow C
    J Pers Med; 2020 Dec; 11(1):. PubMed ID: 33374349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
    Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
    J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of the need for pharmacogenomics testing among physicians in the West Bank of Palestine.
    Jarrar Y; Musleh R; Hamdan A; Ghanim M
    Drug Metab Pers Ther; 2021 Jun; 36(4):289-294. PubMed ID: 34821126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.
    Just KS; Dormann H; Schurig M; Böhme M; Fracowiak J; Steffens M; Scholl C; Seufferlein T; Gräff I; Schwab M; Stingl JC
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32527038
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Knowledge, Attitude, and Perceptions of Pharmacists and Pharmacy Students towards Pharmacogenomics in Zimbabwe.
    Muzoriana N; Gavi S; Nembaware V; Dhoro M; Matimba A
    Pharmacy (Basel); 2017 Jun; 5(3):. PubMed ID: 28970448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
    Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
    Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the need for pharmacogenomics testing among physicians in the West Bank of Palestine.
    Jarrar Y; Musleh R; Hamdan A; Ghanim M
    Drug Metab Pers Ther; 2021 Jun; ():. PubMed ID: 34087962
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison.
    Monnin P; Legrand J; Husson G; Ringot P; Tchechmedjiev A; Jonquet C; Napoli A; Coulet A
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):139. PubMed ID: 30999867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
    Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
    Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark.
    Lunenburg CATC; Ishtiak-Ahmed K; Werge T; Gasse C
    Pharmacopsychiatry; 2022 Mar; 55(2):95-107. PubMed ID: 34753194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020).
    Kim JA; Ceccarelli R; Lu CY
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33806453
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project.
    Kawame H; Fukushima A; Fuse N; Nagami F; Suzuki Y; Sakurai-Yageta M; Yasuda J; Yamaguchi-Kabata Y; Kinoshita K; Ogishima S; Takai T; Kuriyama S; Hozawa A; Nakaya N; Nakamura T; Minegishi N; Sugawara J; Suzuki K; Tomita H; Uruno A; Kobayashi T; Aizawa Y; Tokutomi T; Yamamoto K; Ohneda K; Kure S; Aoki Y; Katagiri H; Ishigaki Y; Sawada S; Sasaki M; Yamamoto M
    J Hum Genet; 2022 Jan; 67(1):9-17. PubMed ID: 34234266
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework.
    van der Wouden CH; Paasman E; Teichert M; Crone MR; Guchelaar HJ; Swen JJ
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32192029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug Prescribing and Outcomes After Pharmacogenomic Testing in a Developmental and Behavioral Health Pediatric Clinic.
    Patel JN; Mueller MK; Guffey WJ; Stegman J
    J Dev Behav Pediatr; 2020 Jan; 41(1):65-70. PubMed ID: 31688658
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Physicians' Knowledge and Attitudes Regarding Point-of-Care Pharmacogenetic Testing: A Hospital-Based Cross-Sectional Study.
    Muflih S; Alshogran OY; Al-Azzam S; Al-Taani G; Khader YS
    Pharmgenomics Pers Med; 2021; 14():655-665. PubMed ID: 34103970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing.
    Wang L; Liu H; Chute CG; Zhu Q
    BioData Min; 2015; 8():9. PubMed ID: 25729430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
    Virelli CR; Mohiuddin AG; Kennedy JL
    Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.